Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1

Oncogene

Volumn 29, Issue 31, 2010, Pages 4412-4423

  Dash, R ^a   Su, Z Z ^a   Lee, S G ^a,c   Azab, B ^a   Boukerche, H ^a,d   Sarkar, D ^a,b   Fisher, P B ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Kyung Hee University   (South Korea)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

AP 1; c Jun; CCN1; SARI; transcriptional regulation

Indexed keywords

ADENOVIRUS VECTOR; CYSTEINE RICH PROTEIN 61; INTERFERON; PROTEIN C JUN; REGULATOR PROTEIN; SUPPRESSOR OF ACTIVATOR PROTEIN 1; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYBRIDIZATION; MALE; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; TUMOR CELL;

ANIMALS; CELL ADHESION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE-RICH PROTEIN 61; DISEASE PROGRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; RATS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; VALIDATION STUDIES AS TOPIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE; RATTUS;

EID: 77955471994     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.194     Document Type: Article

References (44)

1. Angel P, Karin M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157.
2. Bork P. (1993). The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327: 125-130.
3. Brigstock DR. (1999). The connective tissue growth factor/cysteinerich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 20: 189-206.
4. Chen CC, Mo FE, Lau LF. (2001). The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 276: 47329-47337.
5. Chinenov Y, Kerppola TK. (2001). Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20: 2438-2452.
6. Dash R, Dmitriev I, Su ZZ, Bhutia SK, Azab B, Vozhilla N et al. (2010). Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells. Cancer Gene Ther.
7. Echlin DR, Tae HJ, Mitin N, Taparowsky EJ. (2000). B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene 19: 1752-1763.
8. Eferl R, Wagner EF. (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868.
9. Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH et al. (2001). Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98: 1853-1858.
10. Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H et al. (2005). Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 11: 7243-7254.
11. Grotendorst GR, Lau LF, Perbal B. (2000). CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily. Endocrinology 141: 2254-2256.
12. Han JS, Macarak E, Rosenbloom J, Chung KC, Chaqour B. (2003). Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways. Eur J Biochem 270: 3408-3421.
13. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. (2009). Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
14. Jiang H, Fisher PB. (1993). Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol Cell Differentiation 1: 285-299.
15. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE. (2004). Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 11: 781-791.
16. Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, Fisher PB. (2002). The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 21: 708-718.
17. Lebedeva IV, Sarkar D, Su ZZ, Kitada S, Dent P, Stein CA et al. (2003). Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 22: 8758-8773.
18. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB. (2008). Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27: 1114-1121.
19. Leu SJ, Chen N, Chen CC, Todorovic V, Bai T, Juric V et al. (2004). Targeted mutagenesis of the angiogenic protein CCN1 (CYR61). Selective inactivation of integrin alpha6beta1-heparan sulfate proteoglycan coreceptor-mediated cellular functions. J Biol Chem 279: 44177-44187.
20. Ludes-Meyers JH, Liu Y, Munoz-Medellin D, Hilsenbeck SG, Brown PH. (2001). AP-1 blockade inhibits the growth of normal and malignant breast cells. Oncogene 20: 2771-2780. (Pubitemid 32549834)
21. Maki Y, Bos TJ, Davis C, Starbuck M, Vogt PK. (1987). Avian sarcoma virus 17 carries the jun oncogene. Proc Natl Acad Sci USA 84: 2848-2852.
22. Matthews CP, Colburn NH, Young MR. (2007). AP-1 a target for cancer prevention. Curr Cancer Drug Targets 7: 317-324.
23. Menendez JA, Vellon L, Mehmi I, Teng PK, Griggs DW, Lupu R. (2005). A novel CYR61-triggered '0CYR61-alphavbeta3 integrin loop0' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. Oncogene 24: 761-779.
24. Nguyen N, Kuliopulos A, Graham RA, Covic L. (2006). Tumorderived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells. Cancer Res 66: 2658-2665.
25. O'Kelly J, Chung A, Lemp N, Chumakova K, Yin D, Wang HJ et al. (2008). Functional domains of CCN1 (Cyr61) regulate breast cancer progression. Int J Oncol 33: 59-67.
26. O'Kelly KH. (2005). The role of CCN1 in tumorigenesis and cancer progression. In: PB (ed). CCN Proteins. Imperial College Press: London, UK.
27. Roskelley CD, Bissell MJ. (2002). The dominance of the microenvironment in breast and ovarian cancer. Semin Cancer Biol 12: 97-104.
28. Ryseck RP, Bravo R. (1991). c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene 6: 533-542.
29. Sarkar D, Su ZZ, Vozhilla N, Park ES, Gupta P, Fisher PB. (2005). Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Proc Natl Acad Sci USA 102: 14034-14039.
30. Schraml BU, Hildner K, Ise W, Lee W-L, Smith WA, Solomon B et al. (2009). The AP-1 transcription factor Batf controls TH17 differentiation. Nature 460: 405-409.
31. Shimizu T, Okayama A, Inoue T, Takeda K. (2005). Analysis of gene expression during staurosporine-induced neuronal differentiation of human prostate cancer cells. Oncol Rep 14: 441-448.
32. Su Z, Shi Y, Friedman R, Qiao L, McKinstry R, Hinman D et al. (2001). PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells. Nucleic Acids Res 29: 1661-1671.
33. Su ZZ, Madireddi MT, Lin JJ, Young CS, Kitada S, Reed JC et al. (1998). The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci USA 95: 14400-14405.
34. Su ZZ, Lebedeva IV, Sarkar D, Gopalkrishnan RV, Sauane M, Sigmon C et al. (2003). Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 22: 1164-1180.
35. Su ZZ, Lee SG, Emdad L, Lebdeva IV, Gupta P, Valerie K et al. (2008). Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN). Proc Natl Acad Sci USA 105: 20906-20911.
36. Taddei I, Faraldo MM, Teuliere J, Deugnier MA, Thiery JP, Glukhova MA. (2003). Integrins in mammary gland development and differentiation of mammary epithelium. J Mammary Gland Biol Neoplasia 8: 383-394.
37. Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R. (2002a). Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 21: 8178-8185. (Pubitemid 35454421)
38. Tsai MS, Bogart DF, Li P, Mehmi I, Lupu R. (2002b). Expression and regulation of Cyr61 in human breast cancer cell lines. Oncogene 21: 964-973.
39. Vandel L, Montreau N, Vial E, Pfarr CM, Binetruy B, Castellazzi M. (1996). Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization. Mol Cell Biol 16: 1881-1888.
40. Vellon L, Menendez JA, Lupu R. (2005). AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. Oncogene 24: 3759-3773.
41. Williams KL, Nanda I, Lyons GE, Kuo CT, Schmid M, Leiden JM et al. (2001). Characterization of murine BATF: a negative regulator of activator protein-1 activity in the thymus. Eur J Immunol 31: 1620-1627.
42. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V et al. (2000). TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 28: 316-319.
43. Xie D, Miller CW, O'Kelly J, Nakachi K, Sakashita A, Said JW et al. (2001). Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem 276: 14187-14194.
44. Zullo AJ, Benlagha K, Bendelac A, Taparowsky EJ. (2007). Sensitivity of NK1.1 negative NKT cells to transgenic BATF defines a role for activator protein-1 in the expansion and maturation of immature NKT cells in the thymus. J Immunol 178: 58-66.